vs
Side-by-side financial comparison of HEARTLAND EXPRESS INC (HTLD) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $179.4M, roughly 1.6× HEARTLAND EXPRESS INC). Bio-Techne runs the higher net margin — 12.8% vs -10.8%, a 23.7% gap on every dollar of revenue. On growth, Bio-Techne posted the faster year-over-year revenue change (-6.4% vs -26.1%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -18.5%).
Heartland Express is an American trucking company headquartered in North Liberty, Iowa. The company offers truckload shipping services across the United States.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
HTLD vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $179.4M | $295.9M |
| Net Profit | $-19.4M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | -12.7% | 18.4% |
| Net Margin | -10.8% | 12.8% |
| Revenue YoY | -26.1% | -6.4% |
| Net Profit YoY | -949.2% | 68.3% |
| EPS (diluted) | $-0.24 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $179.4M | $295.9M | ||
| Q3 25 | $196.5M | — | ||
| Q2 25 | $210.4M | $317.0M | ||
| Q1 25 | $219.4M | $316.2M | ||
| Q4 24 | $242.6M | $297.0M | ||
| Q3 24 | $259.9M | $289.5M | ||
| Q2 24 | $274.8M | $306.1M | ||
| Q1 24 | $270.3M | $303.4M |
| Q4 25 | $-19.4M | $38.0M | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $-10.9M | $-17.7M | ||
| Q1 25 | $-13.9M | $22.6M | ||
| Q4 24 | $-1.9M | $34.9M | ||
| Q3 24 | $-9.3M | $33.6M | ||
| Q2 24 | $-3.5M | $40.6M | ||
| Q1 24 | $-15.1M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | -12.7% | 18.4% | ||
| Q3 25 | -3.7% | — | ||
| Q2 25 | -5.9% | -7.5% | ||
| Q1 25 | -6.8% | 12.2% | ||
| Q4 24 | 0.4% | 16.0% | ||
| Q3 24 | -2.7% | 13.8% | ||
| Q2 24 | 0.1% | 15.0% | ||
| Q1 24 | -5.3% | 22.1% |
| Q4 25 | -10.8% | 12.8% | ||
| Q3 25 | -4.2% | — | ||
| Q2 25 | -5.2% | -5.6% | ||
| Q1 25 | -6.3% | 7.1% | ||
| Q4 24 | -0.8% | 11.7% | ||
| Q3 24 | -3.6% | 11.6% | ||
| Q2 24 | -1.3% | 13.3% | ||
| Q1 24 | -5.6% | 16.2% |
| Q4 25 | $-0.24 | $0.24 | ||
| Q3 25 | $-0.11 | — | ||
| Q2 25 | $-0.14 | $-0.11 | ||
| Q1 25 | $-0.18 | $0.14 | ||
| Q4 24 | $-0.03 | $0.22 | ||
| Q3 24 | $-0.12 | $0.21 | ||
| Q2 24 | $-0.04 | $0.26 | ||
| Q1 24 | $-0.19 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.5M | $172.9M |
| Total DebtLower is stronger | $154.1M | $260.0M |
| Stockholders' EquityBook value | $755.3M | $2.0B |
| Total Assets | $1.2B | $2.5B |
| Debt / EquityLower = less leverage | 0.20× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.5M | $172.9M | ||
| Q3 25 | $32.7M | — | ||
| Q2 25 | $22.9M | $162.2M | ||
| Q1 25 | $23.9M | $140.7M | ||
| Q4 24 | $12.8M | $177.5M | ||
| Q3 24 | $30.7M | $187.5M | ||
| Q2 24 | $23.9M | $152.9M | ||
| Q1 24 | $23.8M | $145.3M |
| Q4 25 | $154.1M | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | $187.9M | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $755.3M | $2.0B | ||
| Q3 25 | $775.6M | — | ||
| Q2 25 | $786.7M | $1.9B | ||
| Q1 25 | $807.7M | $2.0B | ||
| Q4 24 | $822.6M | $2.1B | ||
| Q3 24 | $825.7M | $2.1B | ||
| Q2 24 | $836.8M | $2.1B | ||
| Q1 24 | $848.8M | $2.0B |
| Q4 25 | $1.2B | $2.5B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | $2.6B | ||
| Q1 25 | $1.3B | $2.6B | ||
| Q4 24 | $1.3B | $2.7B | ||
| Q3 24 | $1.4B | $2.7B | ||
| Q2 24 | $1.4B | $2.7B | ||
| Q1 24 | $1.5B | $2.7B |
| Q4 25 | 0.20× | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | 0.23× | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.9M | — |
| Free Cash FlowOCF − Capex | $-44.2M | — |
| FCF MarginFCF / Revenue | -24.6% | — |
| Capex IntensityCapex / Revenue | 33.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-66.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.9M | — | ||
| Q3 25 | $27.5M | — | ||
| Q2 25 | $21.0M | $98.2M | ||
| Q1 25 | $25.8M | $41.1M | ||
| Q4 24 | $37.8M | $84.3M | ||
| Q3 24 | $35.6M | $63.9M | ||
| Q2 24 | $40.0M | $75.5M | ||
| Q1 24 | $31.0M | $81.0M |
| Q4 25 | $-44.2M | — | ||
| Q3 25 | $-12.2M | — | ||
| Q2 25 | $-12.8M | $93.3M | ||
| Q1 25 | $2.3M | $31.0M | ||
| Q4 24 | $-45.5M | $77.5M | ||
| Q3 24 | $24.6M | $54.7M | ||
| Q2 24 | $29.4M | $57.5M | ||
| Q1 24 | $26.3M | $64.5M |
| Q4 25 | -24.6% | — | ||
| Q3 25 | -6.2% | — | ||
| Q2 25 | -6.1% | 29.4% | ||
| Q1 25 | 1.0% | 9.8% | ||
| Q4 24 | -18.8% | 26.1% | ||
| Q3 24 | 9.5% | 18.9% | ||
| Q2 24 | 10.7% | 18.8% | ||
| Q1 24 | 9.7% | 21.3% |
| Q4 25 | 33.0% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 16.1% | 1.5% | ||
| Q1 25 | 10.7% | 3.2% | ||
| Q4 24 | 34.3% | 2.3% | ||
| Q3 24 | 4.2% | 3.2% | ||
| Q2 24 | 3.8% | 5.9% | ||
| Q1 24 | 1.7% | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTLD
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
